Is Aethlon Medical a Good Healthtech Company to Own? By StockNews
Aethlon Medical, a therapeutic technology company (AEMD), has seen positive changes in its business but lost more money during the second quarter. So, let’s find out if it is wise to bet on the stock now.Medical devices technology company Aethlon Medical, Inc. (AEMD) is known for its Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. Following the Hemopurifier success, many clinical researchers are interested in participating in their ongoing clinical trial to help patients with SARS/CoV-2/COVID-19.
The stock lost 24% in the last three months. The stock is also trading 69% lower than its 52-week low of $12.49. This was due to Reddit’s short squeeze. Moreover, AEMD’s losses widened in the second quarter. So, AEMD’s near-term prospects look bleak.
Here’s what could influence AEMD’s performance in the upcoming months:
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.